Roscoe Medical, Inc. – Trademark Portfolio
Entity Type: 03
Roscoe Medical, Inc. holds 24 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 18 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 6 Nice Classification classes. Currently, 11 trademarks are registered. Notable registered marks include QUATTRO, US 1000, SUB ZERO, INTENSITY, and TENS CELL. The owner is based in Strongsville, OH.
21973 Commerce Parkway
Strongsville, OH 44149
Showing of trademarks Trademarks
Trademark Classifications
Roscoe Medical, Inc.'s trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Roscoe Medical, Inc. have?
Roscoe Medical, Inc. has 24 U.S. trademarks filed with the USPTO. Of these, 11 registered, 1 abandoned, 12 cancelled.
What trademark classes does Roscoe Medical, Inc. file in?
Roscoe Medical, Inc. files trademarks across 6 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 21 (Housewares), Class 39 (Transportation & Storage), Class 12 (Vehicles). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Roscoe Medical, Inc.'s most well-known trademarks?
Roscoe Medical, Inc.'s registered trademark portfolio includes well-known marks such as QUATTRO, US 1000, SUB ZERO, INTENSITY, and TENS CELL. These are among 11 currently registered trademarks in the portfolio.
What is Roscoe Medical, Inc.'s trademark registration success rate?
Roscoe Medical, Inc. has a 46% trademark registration rate, with 11 out of 24 resolved applications resulting in successful registration. Currently, 0 applications are pending review.